Amira's Three-Way Package' Deal Could Help Form Others

Jan. 16, 2006

By Randy Osborne

After Win, Emisphere Demands Lilly Pay For 'Secret' Research

Jan. 13, 2006

By Randy Osborne

Amira's Potential $287M Pact With Roche: New Deal Model?

Jan. 12, 2006

By Randy Osborne

After Late 2005's Hard Times, Industry Upbeat, Going Strong

Jan. 11, 2006

By Randy Osborne

More Good Phase III Results With Celgene's Thalidomide

Jan. 10, 2006

By Randy Osborne

Trubion's Anti-CD20 SMIP Platform: 'Best Thing Ever'?

Jan. 9, 2006

By Randy Osborne

Millennium's CEO Pledges Still More Velcade Growth

Jan. 9, 2006

By Randy Osborne

NeoPharm Raising $35.7M; Pivotal Phase III Goes On

Jan. 6, 2006

By Randy Osborne

Amarin, MultiCell License Deal Worth Up To $275M

Jan. 4, 2006

By Randy Osborne

Tibotec Submits NDA: New Protease Inhibitor For HIV

Jan. 4, 2006

By Randy Osborne